Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Maraviroc A Review of its Use in the Management of CCR5-Tropic HIV-1 Infection
Caroline M. Perry
DRUGS (2010)
Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry
Christoph Koenigs et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density
S Willey et al.
ANTIVIRAL RESEARCH (2005)
Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-Specific antibodies with human immunodeficiency virus-neutralizing activity
S Khurana et al.
JOURNAL OF VIROLOGY (2005)
Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent
N Signoret et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Chemokine receptor CCR5: insights into structure, function, and regulation
M Oppermann
CELLULAR SIGNALLING (2004)
Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies
C Blanpain et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Pathways for internalization and recycling of the chemokine receptor CCR5
A Mueller et al.
BLOOD (2002)
Share Paper
